JOSEPH HOLOSHITZ, MD
Osteopathic Medicine in Ann Arbor, MI
License number
Michigan 4301057096
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Michigan 4301057096
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
1500 Floor Taubman Ctr, Ann Arbor, MI 48109
Phone
(734) 647-5900
(734) 936-2047
(734) 936-2047
Personal information
See more information about JOSEPH HOLOSHITZ at radaris.comName
Address
Phone
3580 Windemere Dr, Ann Arbor, MI 48105
3580 Windemere Ct, Ann Arbor, MI 48105
Organization information
See more information about JOSEPH HOLOSHITZ at bizstanding.comJoseph Holoshitz MD
1500 E Medical Ctr Dr, Ann Arbor, MI 48109
Industry:
Internist
Site:
Phone:
(734) 647-5900 (Phone)
Joseph Holoshitz
Professional information
Dr. Joseph Holoshitz, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Rheumatology
Address:
University Of MI Medcl Ctr-RHU
1500 E Medical Center Dr, Ann Arbor 48109
(734) 647-5900 (Phone)
1500 E Medical Center Dr, Ann Arbor 48109
(734) 647-5900 (Phone)
Procedures:
Joint Drainage, Steroid Injections, Trigger Point Injections
Conditions:
Amyloidosis, Antiphospholipid Syndrome (APS), Arthritis, Bursitis, Carpal Tunnel Syndrome, Chronic Neck Pain, Classic Polyarteritis Nodosa, Degenerative Disc Disease, Enthesopathy of Hip (incl. Trochanteric Bursitis), Enthesopathy of Knee (incl. Bursitis of Knee), Fibromyalgia, Giant Cell Arteritis, Gout, Hepatitis B - Immune Response, Immune Thrombocytopenic Purpura (ITP), Lateral & Medial Epicondylitis (Tennis & Golf Elbow), Low Back Pain, Lupus Erythematosus, Marfan Syndrome, Osteoarthritis, Osteoarthritis of Hand or Wrist, Osteoarthritis of Hip, Osteoarthritis of Knee, Osteoarthritis of Spine, Osteopenia, Osteoporosis, Patellofemoral Pain Syndrome or Knee Pain, Polymyalgia Rheumatica (PMR), Polymyositis, Raynaud's Disease, Rheumatoid Arthritis, Sjögren's Syndrome, Spondylitis, Still's Disease, Systemic Lupus Erythematosus (SLE), Systemic Sclerosis, Takayasu's Arteritis, Vasculitis
Certifications:
Internal Medicine, 2000, Rheumatology, 2002
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University Of MI Medcl Ctr-RHU
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
Hadassah Medical School, The Hebrew University Of Jerusalem
Graduated: 1981
Hadassah Medical School, The Hebrew University Of Jerusalem
Graduated: 1981
Joseph Holoshitz, Ann Arbor MI
Specialties:
Internal Medicine, Rheumatology
Work:
Ann Arbor Veterans Affairs Medical Center
2215 Fuller Rd, Ann Arbor, MI 48105 University of Michigan Medical School
1500 E Medical Center Dr, Ann Arbor, MI 48109
2215 Fuller Rd, Ann Arbor, MI 48105 University of Michigan Medical School
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
Hebrew University, Hadassah Medical School (1981)
Compositions For Treating Autoimmune Disease
US Patent:
6518259, Feb 11, 2003
Filed:
May 22, 2000
Appl. No.:
09/575612
Inventors:
Joseph Holoshitz - Ann Arbor MI
James A. Shayman - Ann Arbor MI
Shi-Yu Tan - Ann Arbor MI
James A. Shayman - Ann Arbor MI
Shi-Yu Tan - Ann Arbor MI
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 3166
US Classification:
514114, 514 24, 514 44, 514642
Abstract:
Methods and compositions are described for treating and diagnosing autoimmune diseases, and in particular for treating and detecting rheumatoid arthritis. Treatment is described with a new class of anti-RA drug, namely compounds that inhibit proliferation and induce apoptosis.
Joseph Holoshitz, Ann Arbor MI
Specialties:
Rheumatologist
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
Compositions And Methods For Treating Autoimmune Disease
US Patent:
6098631, Aug 8, 2000
Filed:
Jan 21, 1998
Appl. No.:
9/009906
Inventors:
Joseph Holoshitz - Ann Arbor MI
James A. Shayman - Ann Arbor MI
Shi-Yu Tan - Ann Arbor MI
James A. Shayman - Ann Arbor MI
Shi-Yu Tan - Ann Arbor MI
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61B 1900
US Classification:
128898
Abstract:
Methods and compositions are described for treating and diagnosing autoimmune diseases, and in particular for treating and detecting rheumatoid arthritis. Treatment is described with a new class of anti-RA drug, namely compounds that inhibit proliferation and induce apoptosis.
Compositions And Methods For Inducing An Immune Response
US Patent:
2012014, Jun 7, 2012
Filed:
Dec 20, 2011
Appl. No.:
13/331354
Inventors:
Joseph Holoshitz - Ann Arbor MI, US
Song Ling - Ypsilanti MI, US
Xiujun Pi - Ann Arbor MI, US
Denise de Almeida - Dearborn MI, US
Song Ling - Ypsilanti MI, US
Xiujun Pi - Ann Arbor MI, US
Denise de Almeida - Dearborn MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 39/00, C07K 19/00, A61P 31/04, A61P 37/04, A61P 35/00, C07K 7/06, A61K 39/02
US Classification:
4241851, 530330, 530350
Abstract:
The present invention provides compositions and methods for inducing an immune response in a subject. In particular, the present invention provides compositions comprising immunostimulatory ligands (ISL) and methods of inducing an immune response in a subject therewith. Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.
Methods And Compositions For The Treatment Of Diseases Associated With Signal Transduction Aberrations
US Patent:
7074893, Jul 11, 2006
Filed:
Feb 25, 2004
Appl. No.:
10/786774
Inventors:
Joseph Holoshitz - Ann Arbor MI, US
Song Ling - Ypsilanti MI, US
Song Ling - Ypsilanti MI, US
Assignee:
Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 38/04
US Classification:
530330, 530300
Abstract:
The present invention relates generally to therapeutic methods and compositions. More particularly, methods and compositions to counteract and reverse disease-causing signaling defects in diseases with underlying signal transduction aberrations, including but not limited to Alzheimer's Disease.
Methods And Compositions For The Treatment Of Mhc-Associated Conditions
US Patent:
7208154, Apr 24, 2007
Filed:
May 13, 2004
Appl. No.:
10/845407
Inventors:
Joseph Holoshitz - Ann Arbor MI, US
Song Ling - Ypsilanti MI, US
Song Ling - Ypsilanti MI, US
Assignee:
Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 38/04
US Classification:
4241781, 514 2, 530330
Abstract:
The present invention relates to methods and compositions for counteracting and reversing disease-causing signaling defects in disorders with underlying signal transduction aberrations, including but not limited to rheumatoid arthritis.
Methods And Compositions For The Treatment Of Diseases Associated With Signal Transduction Aberrations
US Patent:
2003009, May 22, 2003
Filed:
Jun 3, 2002
Appl. No.:
10/161959
Inventors:
Joseph Holoshitz - Ann Arbor MI, US
Song Ling - Ann Arbor MI, US
Song Ling - Ann Arbor MI, US
Assignee:
The Regents Of The University Of Michigan
International Classification:
A61K038/17
US Classification:
514/012000, 530/359000
Abstract:
The present invention relates generally to therapeutic methods and compositions. More particularly, methods and compositions to counteract and reverse disease-causing signaling defects in diseases with underlying signal transduction aberrations, including but not limited to Alzheimer's Disease.
Compositions And Methods For Treating Autoimmune Disease
US Patent:
2003011, Jun 26, 2003
Filed:
Oct 31, 2002
Appl. No.:
10/285011
Inventors:
Joseph Holoshitz - Ann Arbor MI, US
James Shayman - Ann Arbor MI, US
Shi-Yu Tan - Ann Arbor MI, US
James Shayman - Ann Arbor MI, US
Shi-Yu Tan - Ann Arbor MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K031/66, A61K031/445, A61K031/225, A61K031/495
US Classification:
514/114000, 514/255010, 514/328000, 514/561000, 514/547000
Abstract:
Methods and compositions are described for treating and diagnosing autoimmune diseases, and in particular for treating and detecting rheumatoid arthritis. Treatment is described with a new class of anti-RA drug, namely compounds that inhibit proliferation and induce apoptosis.